AAAAAA
Results:
1-7
|
Results: 7
Authors:
Cao, M
Do, LV
Hoffman, NW
Kwan, ML
Little, JK
McGilvray, JM
Morris, CB
Soderberg, BC
Wierzbicki, A
Cundari, TR
Lake, CH
Valente, EJ
Citation: M. Cao et al., Kinetics of substitution of weakly coordinating nitrate by chloride in (eta(5)-Cp)Ru(CO)(ER3)ONO2 (ER3 = AsPh3, PPh3, P(p-anisyl)(3), PPh2(o-anisyl),P(OPh)(3)) in dichloromethane, ORGANOMETAL, 20(11), 2001, pp. 2270-2279
Authors:
Morris, CB
Thanawastien, A
Sullivan, DE
Clements, JD
Citation: Cb. Morris et al., Identification of a peptide capable of inducing an HIV-1 Tat-specific CTL response, VACCINE, 20(1-2), 2001, pp. 12-15
Authors:
Morris, CB
Cheng, E
Thanawastien, A
Cardenas-Freytag, L
Clements, JD
Citation: Cb. Morris et al., Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 Env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G), VACCINE, 18(18), 2000, pp. 1944-1951
Authors:
Morris, CB
Citation: Cb. Morris, Beyond autobiography: The journey of 'Sobre los angeles' (Rafael Alberti), AN LIT ESP, 24(1-2), 1999, pp. 297-316
Authors:
Kelly, GD
Morris, CB
Offermann, MK
Citation: Gd. Kelly et al., Lack of responsiveness of a nuclear factor-kappa B-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells, VIROLOGY, 263(1), 1999, pp. 128-138
Authors:
Wang, ZD
Morris, GF
Reed, JC
Kelly, GD
Morris, CB
Citation: Zd. Wang et al., Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein, VIROLOGY, 257(2), 1999, pp. 502-510
Authors:
Barillari, G
Sgadari, C
Palladino, C
Gendelman, R
Caputo, A
Morris, CB
Nair, BC
Markham, P
Nel, A
Sturzl, M
Ensoli, B
Citation: G. Barillari et al., Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha(v)beta(3), J IMMUNOL, 163(4), 1999, pp. 1929-1935
Risultati:
1-7
|